This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ronsin, C. Articles by Denoyel, G.-A. Search for Related Content PubMed PubMed Citation Articles by Ronsin, C. Articles by Denoyel, G.-A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 2006, p. 1390-1399, Vol. 44, No. 4
0095-1137/06/$08.00+0     doi:10.1128/JCM.44.4.1390-1399.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Evaluation of the COBAS AmpliPrep-Total Nucleic Acid Isolation-COBAS TaqMan Hepatitis B Virus (HBV) Quantitative Test and Comparison to the VERSANT HBV DNA 3.0 Assay

Laboratoire L.C.L., Service de Biologie Moléculaire, 94208 Ivry sur Seine, France,¹ Laboratoire Marcel Mérieux, Service d'Infectiologie Moléculaire, 19 Avenue Tony Garnier, BP 7322, 69365 Lyon Cedex 07, France²

Received 20 July 2005/ Returned for modification 5 December 2005/ Accepted 2 February 2006

Quantitative detection of hepatitis B virus (HBV) in serum or plasma has become the most direct and reliable method for monitoring chronic hepatitis B. Here, we report the performance characteristics of a real-time PCR hepatitis B DNA quantitative assay, the COBAS TaqMan (CTM) HBV test (Roche Diagnostics, Meylan, France), in combination with an automated DNA extraction on the COBAS AmpliPrep (CAP) instrument using the total nucleic acid isolation kit (TNAI kit), a generic reagent for nucleic acid isolation (both from Roche Diagnostics). The linearity, accuracy, and specificity of the CAP-TNAI-CTM HBV test were evaluated using various reference panels and standards (HBV panel 2004 from Quality Control for Molecular Diagnostics, OptiQuant HBV panel from AcroMetrix, WHO International Standard for HBV, and Teragenix hepatitis B genotype panel). Quantitative results show that the CAP-TNAI-CTM HBV test performed well with respect to linearity, accuracy, and reproducibility from at least 100 to 500,000 HBV DNA IU/ml. Based on the log₁₀ IU of HBV DNA/ml measured, the intra-assay variation ranged from 2.49% to 8.46% and the interassay variation ranged from 1.88% to 7.83%. The test was extremely sensitive and could detect samples containing HBV DNA below the reported quantification threshold (<30 IU/ml). All HBV genotypes were correctly amplified, and no cross-contamination occurred during the automated sample preparation. In addition, 402 human serum samples were tested comparatively to the VERSANT HBV DNA 3.0 assay (bDNA; Bayer Diagnostics, Puteaux, France). The viral load results of the CAP-TNAI-CTM test and bDNA were significantly correlated, but the agreement between the two tests was poor, with large differences between results for individual samples. The hands-on time was estimated to be reduced from 2.30 h with bDNA to 45 min with the CAP-TNAI-CTM test, and up to 84 samples were completely processed within a working day. Overall, the performance characteristics of the CAP-TNAI-CTM test demonstrated that it provides a high-throughput sensitive and reliable method for quantitation of HBV DNA levels in the routine molecular laboratory.

This article has been cited by other articles:

• Chevaliez, S., Bouvier-Alias, M., Laperche, S., Pawlotsky, J.-M. (2008). Performance of the Cobas AmpliPrep/Cobas TaqMan Real-Time PCR Assay for Hepatitis B Virus DNA Quantification. J. Clin. Microbiol. 46: 1716-1723 [Abstract] [Full Text]  
• Bayram, A, Erkilic, S, Ozkur, A, Bayram, M, Sari, I (2008). Quantification of intrahepatic total hepatitis B virus DNA in chronic hepatitis B patients and its relationship with liver histology. J. Clin. Pathol. 61: 338-342 [Abstract] [Full Text]  
• Thibault, V., Pichoud, C., Mullen, C., Rhoads, J., Smith, J. B., Bitbol, A., Thamm, S., Zoulim, F. (2007). Characterization of a New Sensitive PCR Assay for Quantification of Viral DNA Isolated from Patients with Hepatitis B Virus Infections. J. Clin. Microbiol. 45: 3948-3953 [Abstract] [Full Text]  
• Valsamakis, A. (2007). Molecular Testing in the Diagnosis and Management of Chronic Hepatitis B. Clin. Microbiol. Rev. 20: 426-439 [Abstract] [Full Text]  
• Allice, T., Cerutti, F., Pittaluga, F., Varetto, S., Gabella, S., Marzano, A., Franchello, A., Colucci, G., Ghisetti, V. (2007). COBAS AmpliPrep-COBAS TaqMan Hepatitis B Virus (HBV) Test: a Novel Automated Real-Time PCR Assay for Quantification of HBV DNA in Plasma. J. Clin. Microbiol. 45: 828-834 [Abstract] [Full Text]  
• Hui, C.-K., Bowden, S., Zhang, H.-Y., Wong, A., Lewin, S., Rousseau, F., Mommeja-Marin, H., Lee, N. P., Luk, J. M., Locarnini, S., Leung, N., Naoumov, N. V., Lau, G. K. K. (2006). Comparison of Real-Time PCR Assays for Monitoring Serum Hepatitis B Virus DNA Levels during Antiviral Therapy.. J. Clin. Microbiol. 44: 2983-2987 [Abstract] [Full Text]